PCSK9 inhibition in LDL cholesterol reduction: Genetics and therapeutic implications of very low plasma lipoprotein levels

Title
PCSK9 inhibition in LDL cholesterol reduction: Genetics and therapeutic implications of very low plasma lipoprotein levels
Authors
Keywords
Proprotein convertase subtilisin/kexin type 9, Low-density lipoprotein cholesterol, Low-density lipoprotein receptor, Genetics
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 145, Issue -, Pages 58-66
Publisher
Elsevier BV
Online
2014-07-18
DOI
10.1016/j.pharmthera.2014.07.004

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now